616 related articles for article (PubMed ID: 28464252)
1. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
2. The lncARSR/PTEN/Akt/nuclear factor-kappa B feedback regulatory loop contributes to doxorubicin resistance in hepatocellular carcinoma.
Li Y; Li J; Chen H; Wang J; Jiang L; Tan X
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23119. PubMed ID: 35678308
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
6. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
7. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt/SREBP-2/HMGCR pathway.
Huang J; Chen S; Cai D; Bian D; Wang F
Life Sci; 2018 Jun; 203():48-53. PubMed ID: 29678744
[TBL] [Abstract][Full Text] [Related]
9. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway.
Zhuang J; He S; Wang G; Wang G; Ni J; Zhang S; Ye Y; Xia W
Oncol Res; 2018 Sep; 26(8):1257-1265. PubMed ID: 29463348
[TBL] [Abstract][Full Text] [Related]
11. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
Han K; Li C; Zhang X; Shang L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
13. Rap2B knockdown suppresses malignant progression of hepatocellular carcinoma by inactivating the PTEN/PI3K/Akt and ERK1/2 pathways.
Zhu L; Sun Y; Zhang S; Wang L
Mol Cell Biochem; 2020 Mar; 466(1-2):55-63. PubMed ID: 32052247
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma.
Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465
[TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway.
Li X; Yin X; Bao H; Liu C
Mol Cell Probes; 2023 Feb; 67():101877. PubMed ID: 36442661
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA THOR promotes cell proliferation and metastasis in hepatocellular carcinoma.
Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
Gene; 2018 Dec; 678():129-136. PubMed ID: 30098425
[TBL] [Abstract][Full Text] [Related]
20. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]